Item Posts Archive - Page 19 of 1770 - Medivizor
Navigation Menu

Can BCT-100 be safely combined with low-dose cytarabine for older patients with acute myeloid leukemia that cannot receive intensive therapy?

Can BCT-100 be safely combined with low-dose cytarabine for older patients with acute myeloid leukemia that cannot receive intensive therapy?

Posted by on Apr 15, 2023 in Leukemia | 0 comments

In a nutshell This study compared the effectiveness and safety of low-dose (LD) cytarabine (Ara-C; Cytosar-U) with recombinant arginase BCT-100 (BCT-100) to Ara-C alone in older patients with acute myeloid leukemia (AML) that were unsuitable for intensive therapy. The data showed that LD Ara-C (LDAC) combined with BCT-100 resulted in similar...

Read More

Is intermittent fasting safe and effective for individuals with insulin-treated type 2 diabetes?

Is intermittent fasting safe and effective for individuals with insulin-treated type 2 diabetes?

Posted by on Apr 15, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the safety and effectiveness of intermittent fasting (IF) for 3 non-consecutive days a week, over a period of 12 weeks in people with insulin-treated type 2 diabetes (T2D). The authors concluded that this dietary approach was safe and effective for controlling blood glucose, reducing total daily insulin requirements,...

Read More

Evaluating the effectiveness of an 8-week hypopressive exercise training program on urinary incontinence and pelvic floor muscle strength

Evaluating the effectiveness of an 8-week hypopressive exercise training program on urinary incontinence and pelvic floor muscle strength

Posted by on Apr 15, 2023 in Urinary incontinence | 0 comments

In a nutshell The study evaluated the effectiveness of an 8-week hypopressive exercise training program on urinary incontinence (UI) and pelvic floor muscle strength. The data found that hypopressive exercise training improved pelvic floor muscle strength and UI symptoms in these patients. Some background Pelvic floor dysfunction is a common...

Read More

Evaluating the effectiveness of immunomodulators in reducing cardiovascular events in patients with rheumatoid arthritis

Evaluating the effectiveness of immunomodulators in reducing cardiovascular events in patients with rheumatoid arthritis

Posted by on Apr 15, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell The study evaluated the effectiveness of reducing cardiovascular events (CVE) with immunomodulatory (IM) in patients with rheumatoid arthritis (RA). The main finding was that IM showed improvements in vascular inflammation in this group of patients. Some background IMs are drugs that modify the immune system to help the body respond...

Read More

How safe and effective is orally delivered insulin for patients with early-stage type 2 diabetes?

How safe and effective is orally delivered insulin for patients with early-stage type 2 diabetes?

Posted by on Apr 15, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety and effectiveness of different doses of an oral insulin capsule formulation (Capsulin™) to patients with early-stage type 2 diabetes (T2D). The data showed that twice-daily, orally administered Capsulin at a dose of 150 international units (IU) was safe and resulted in a significant lowering...

Read More